Discover 959 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 959
Active & Responsive
Fenofibrate for Prevention of DR Worsening
for
Diabetic Retinopathy
1 location in Salem
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18 - 70+
Code: NCT04661358
Phase3, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
1 location in Salem
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection
for
Benign Neoplasm
1 location in Corvallis
Sponsor: Samaritan Health Services
Sex: All
Age: 18+
Code: NCT05082441
Recruiting
Active & ResponsiveNew
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
for
Gynecologic Cancers, Breast Cancer
1 location in Corvallis
Sponsor: Oregon State University
Sex: Female
Age: 18+
Code: NCT07055854
Phase1, Recruiting
Active & Responsive
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
for
Atherosclerotic Cardiovascular Disease (ASCVD)
1 location in Corvallis
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06813911
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
for
Migraine
1 location in Portland
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70
Code: NCT06972056
Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
1 location in Portland
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase2, Recruiting
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
1 location in Portland
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
1 location in Tigard
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis